| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/17/2003 | EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 09/17/2003 | EP1343894A1 Aopb gene, protein, homologs, fragments and variants thereof, and their use for cell surface display |
| 09/17/2003 | EP1343892A2 Compositions and methods for diagnosing or treating psoriasis |
| 09/17/2003 | EP1343891A2 Colon cancer marker |
| 09/17/2003 | EP1343890A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/17/2003 | EP1343889A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 09/17/2003 | EP1343888A2 Regulation of human chemokine-like receptor |
| 09/17/2003 | EP1343887A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 09/17/2003 | EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/17/2003 | EP1343884A2 Jfy1 protein induces rapid apoptosis |
| 09/17/2003 | EP1343883A2 Aspergillus fumigatus cofilin |
| 09/17/2003 | EP1343880A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 09/17/2003 | EP1343879A1 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 09/17/2003 | EP1343875A2 Sugar beet genes involved in stress tolerance |
| 09/17/2003 | EP1343871A2 Isolation and use of solid tumor stem cells |
| 09/17/2003 | EP1343822A2 Means for the diagnosis and therapy of ctcl |
| 09/17/2003 | EP1343819A1 Hla-a2.1 binding peptides and their uses |
| 09/17/2003 | EP1343818A1 Modified tachykinin receptors |
| 09/17/2003 | EP1343816A2 PROTEINS THAT INTERACT WITH $g(b)TRCP |
| 09/17/2003 | EP1343815A2 Antibacterial treatments |
| 09/17/2003 | EP1343814A2 Immunogenic glycopeptides, screening, preparation and uses |
| 09/17/2003 | EP1343813A1 Novel compounds |
| 09/17/2003 | EP1343812A1 Protein cluster ii |
| 09/17/2003 | EP1343811A1 Methods for preparing purified lipopeptides |
| 09/17/2003 | EP1343809A1 Method of preparing alpha-1 proteinase inhibitor |
| 09/17/2003 | EP1343807A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 09/17/2003 | EP1343532A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 09/17/2003 | EP1343527A2 Adjuvant combination formulations |
| 09/17/2003 | EP1343524A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 09/17/2003 | EP1343522A2 Procollagen (iii) propeptides and related substances for treating fibrotic diseases |
| 09/17/2003 | EP1343520A2 New therapeutic uses of smr1 peptides |
| 09/17/2003 | EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 09/17/2003 | EP1343517A2 Survical promoting ncam binding and ncam ligand biding compounds |
| 09/17/2003 | EP1343514A2 Chlamydia pmp proteins, gene sequences and uses thereof |
| 09/17/2003 | EP1343367A2 Non-human animal disease models |
| 09/17/2003 | EP1187627B1 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 09/17/2003 | EP1159295B1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 09/17/2003 | EP1124941B1 Process for recovering heterologous polypeptides from bacterial cells |
| 09/17/2003 | EP0981627B1 Purified telomerase |
| 09/17/2003 | EP0858463B1 Alcohol-free wet extraction of gluten dough into gliadin and glutenin |
| 09/17/2003 | EP0840784B1 Method of producing and purifying enzymes |
| 09/17/2003 | EP0831937B1 Immunological combination compositions and methods |
| 09/17/2003 | EP0724647A4 Nucleic acid ligands and improved methods for producing the same |
| 09/17/2003 | EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region |
| 09/17/2003 | EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 09/17/2003 | EP0478664B1 Vector-mediated genomic insertion and expression of dna in bcg |
| 09/17/2003 | CN1443243A 修饰的病毒 Modified viruses |
| 09/17/2003 | CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 09/17/2003 | CN1443240A Interferon-like protein zcyto 21 |
| 09/17/2003 | CN1443239A Compositions and methods for therapy and diagnosis of breast cancer |
| 09/17/2003 | CN1443238A Tumor-specific promoters |
| 09/17/2003 | CN1443198A Ghrelin拮抗剂 Ghrelin Antagonist |
| 09/17/2003 | CN1443197A Acid-modified arabinogalactan protein composition |
| 09/17/2003 | CN1443196A Protein complex serving as vehicle for orally administerable medicaments |
| 09/17/2003 | CN1443194A Methods for refolding proteins containing free cysteine residues |
| 09/17/2003 | CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/17/2003 | CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 09/17/2003 | CN1443076A Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine |
| 09/17/2003 | CN1443037A Production of mammals which produce progeny single sex |
| 09/17/2003 | CN1442428A Technology of one kettle method for liquid phase synthesizing thymopentapeptide |
| 09/17/2003 | CN1442427A Trimutant of recombinant human interleukin-2 and its preparation method |
| 09/17/2003 | CN1442200A Medicine for preventing and treating AIDS |
| 09/17/2003 | CN1121413C Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
| 09/17/2003 | CN1121412C Anti fungus peptide and its preparing method and use |
| 09/17/2003 | CN1121411C Efficient gene engineering process for preparing polypeptide medicines |
| 09/16/2003 | USRE38252 Corn cDNA encoding southern leaf blight resistance |
| 09/16/2003 | US6620990 Incubating explant, in the presence of a vector comprising DNA encoding a selectable marker, to produce callus; confers chemical/antibiotic/herbicide resistance |
| 09/16/2003 | US6620988 Coleopteran-resistant transgenic plants and methods of their production using modified Bacillus thuringiensis Cry3Bb nucleic acids |
| 09/16/2003 | US6620985 Given nucleotide sequence; use for enhancing disease resistance of plants |
| 09/16/2003 | US6620925 Recombinant nucleic acid encoding proteins associated with apoptin; use in diagnosis and treatment of autoimmune diseases, tumors and cancer |
| 09/16/2003 | US6620923 Use for treatment of uterine cancer |
| 09/16/2003 | US6620922 Isolated polynucleotide of given sequence; kit |
| 09/16/2003 | US6620918 Isolation of preferential particles from solution; apply sample solution to exchange resin, elute and recover preferential particle from exchange resin |
| 09/16/2003 | US6620917 Mixing polypeptide with a organic acid, incubating and clarifying; hydrolysis; chromatography; use for light weight, high performance fiber, composite and medical applications; formic, acetic, propionic, butyric, valeric acids |
| 09/16/2003 | US6620916 Reacting with amino group of ligand, in presence of transglutaminase, to form an amide bond; lower binding affinity for asialoglycoprotein receptor; accumulates in liver; use as anti-tumor anti-inflammatory and viricide |
| 09/16/2003 | US6620915 Monoclonal antibodies specific for integrin α-d subunit |
| 09/16/2003 | US6620914 Transcription factor islet-brain 1 (IB1) |
| 09/16/2003 | US6620913 Polypeptides of a novel hantavirus |
| 09/16/2003 | US6620912 Novel human protein of given nucleotide sequence; vectors, host cells, antibodies, and recombinant methods; for diagnosis and treatment of disorders including those in the immune system |
| 09/16/2003 | US6620910 Of given amino acid sequence; receptor agonists; increased metabolic stability; longer duration of action; use in treatment of non-insulin-dependent type II diabetes, obesity, and type I diabetes |
| 09/16/2003 | US6620909 Adipocyte complement related protein homolog zacrp2 |
| 09/16/2003 | US6620847 Copolymer-1 improvements in compositions of copolymers |
| 09/16/2003 | US6620795 Expressing an exogenously supplied gene in cells of the airway are disclosed. Lipid carrier-nucleic acid complexes or nucleic acid abre are prepared then delivered via aerosol or systemically to the lung abre or lung plus extrapulmonary |
| 09/16/2003 | US6620790 Stimulate hair growth |
| 09/16/2003 | US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs |
| 09/16/2003 | US6620784 Uses of VEGF-E |
| 09/16/2003 | US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating |
| 09/16/2003 | US6620780 Insulin derivatives |
| 09/16/2003 | US6620619 Three human DNA repair proteins and DNA (RNA) encoding such proteins. The DNA repair proteins may be produced by recombinant DNA techniques. One of the human DNA repair proteins, hmlh1, has been mapped on chromosome 3. |
| 09/16/2003 | US6620615 G-protein coupled receptor—encoding nucleic acids |
| 09/16/2003 | US6620610 For the preparation of transgenic crop plants, such as tobacco, potatoes, beets and maize with increased yield, by altering their nitrogen metabolism |
| 09/16/2003 | US6620594 Uncoupling protein homologue: UCP 3 |
| 09/16/2003 | US6620416 Portions of the human chorionic gonadotropin beta -chain as well as methods for treatment and prevention of disease |
| 09/16/2003 | US6620413 Obesity protein derivative covalently bonded to a nonproteinaceous polymer, wherein said derivative is capable of reducing body weight and/or food intake in an individual |
| 09/16/2003 | US6620406 Methods for treatment of periodontal diseases and lesions using bone morphogenetic proteins |
| 09/16/2003 | US6620403 In vivo chemosensitivity screen for human tumors |
| 09/16/2003 | CA2250274C Method and apparatus for preparing an acellular red blood cell substitute |
| 09/16/2003 | CA2182183C Treatment of ovarian estrogen dependent conditions |
| 09/16/2003 | CA2145985C Vascular endothelial cell growth factor antagonists |
| 09/16/2003 | CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |